# Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer

> **NCT00003903** · NA · COMPLETED · sponsor: **University of Rochester** · enrollment: 150 (estimated)

## Conditions studied

- Osteoporosis
- Prostate Cancer

## Interventions

- **PROCEDURE:** management of therapy complications

## Key facts

- **NCT ID:** NCT00003903
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2013-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003903, "Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00003903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*